Latest News in Biostatistics

A Yale-affiliated team, led by Mihaela Aslan, PhD, left, and Somaia Mohamed, MD, PhD, right, has published a large national study of more than 1.58 million veterans receiving outpatient care for major depressive disorder between 2011 and 2025. The findings appear in JAMA Network Open.

A new study led by Kasia Lipska examined whether newer diabetes medications might help people with type 2 diabetes reduce reliance on insulin. Using VA electronic health record data, researchers compared outcomes among patients starting a GLP-1 receptor agonist versus other commonly prescribed drug classes.

Connecticut enacted a law in 2016 requiring CMV testing for all infants who failed their newborn hearing screen. Researchers led by Aanchal Wats and Carlos Oliveira at Yale School of Medicine analyzed 11 years of data, from 2013 through 2023, within a health system serving about 60% of the state's population, comparing the three years before the mandate with the eight years after.

Robin Masheb, PhD, professor of psychiatry, is senior author of a review in Obesity Reviews that evaluates the impact of behavioral weight management interventions on eating disorder symptoms.

Researchers at Yale School of Medicine recently published two studies that offer new insights into how people interact with wearable devices and health-related content on social media.

Developing technology that makes health care more inclusive was a theme of the 2026 Yale Innovation Summit's Health Track.

INSPIRE’s ability to integrate data across multiple patients and platforms could lead to the development of more targeted, personalized approaches to cancer care.

The YSPH community came together on May 13th to recognize faculty and staff excellence, and to unveil its new ceremonial mace.

Public Health Day highlighted Yale School of Public Health’s commitment to reaching the next generation of potential public health leaders before they have chosen a path and showing them what the field looks like up close.